Patent
   D677377
Priority
Nov 18 2009
Filed
May 04 2010
Issued
Mar 05 2013
Expiry
Mar 05 2027
Assg.orig
Entity
unknown
10
32
n/a
The ornamental design for an inhaler, as shown and described.

FIG. 1 is a top perspective view of an inhaler showing our new design;

FIG. 2 is a front elevation thereof;

FIG. 3 is a rear elevation thereof;

FIG. 4 is a side elevation thereof;

FIG. 5 is a side elevation thereof opposite FIG. 4;

FIG. 6 is an end elevation thereof; and,

FIG. 7 is an end elevation of the end opposite thereof, opposite FIG. 6.

The broken lines only are included to show environment and form no part of the claimed design. All the surfaces adjacent the broken lines are included in the claimed design.

White, John S.

Patent Priority Assignee Title
D795414, Jun 03 2014 GLENMARK SPECIALTY S A Inhaler
D797920, Nov 22 2013 GLENMARK PHARMACEUTICALS LIMITED Inhaler
D804015, Dec 23 2013 GLENMARK PHARMACEUTICALS LIMITED Inhaler
D861852, Aug 13 2015 ADHERIUM NZ LIMITED Compliance monitor for a medicament inhaler
D863529, Feb 19 2016 GLENMARK SPECIALTY S A Inhaler
D938521, Apr 11 2013 Glaxo Group Limited Label set for an inhalation device
D983354, Dec 21 2020 RPC Formatec GmbH Inhaler
D985760, Oct 05 2021 NEUTEC INHALER ILAC SANAYI VE TICARET A. S. Inhalation device
D986406, Jul 21 2020 NiPPharma Co., Ltd. Inhaler for powdered medicaments
ER2312,
Patent Priority Assignee Title
5469843, Nov 06 1992 3M Company Inhalation device
5655523, Apr 28 1989 Adamis Pharmaceuticals Corporation Dry powder inhalation device having deagglomeration/aerosolization structure responsive to patient inhalation
5740793, Apr 28 1989 Adamis Pharmaceuticals Corporation Dry powder inhalation device with elongate carrier for power
7107988, Jul 31 2002 CHIESI FARMACEUTICI S P A Powder inhaler
7495546, May 19 2003 Glaxo Group Limited Display system
20060185672,
20080295833,
20090283095,
20090314291,
20090320837,
20100059052,
20100078022,
20100126507,
D299066, Sep 16 1985 Glaxo Group Limited Inhalator
D342994, Jul 15 1991 Glaxo Group Limited Inhalator
D355029, Jan 21 1993 Boehringer Ingelheim International GmbH Inhaler
D379506, Jul 01 1995 Glaxo Group Limited Inhaler
D499802, Apr 01 2003 CHIESI FARMACEUTICI S P A Powder inhaler
D514222, May 15 2003 Glaxo Group Limited Inhaler
D518171, May 15 2003 Glaxo Group Limited Inhaler
D550350, May 11 2005 Vectura Limited Pharmaceutical product
D557798, Jan 25 2006 VALOIS S A S SOCIETE PAR ACTIONS SIMPLIFIEE Inhaler
D557799, Jan 25 2006 VALOIS S A S SOCIETE PAR ACTIONS SIMPLIFIEE Inhaler
D560793, Aug 06 2003 Pfizer Limited Inhaler
D569967, Aug 06 2003 Pfizer Limited Inhaler
D576724, Sep 07 2006 BANG & OLUFSEN MEDICOM A S Inhaler
D585541, Apr 23 2007 Bang & Olufsen Medicom A/S Inhalator
D585978, Apr 23 2007 Bang & Olufsen Medicom A/S Inhalator
D590495, Mar 28 2007 Cipla Limited Multidose inhaler
D590938, Jul 13 2007 Cipla Limited Multidose inhaler
D596432, Nov 23 2007 VECTURA DELIVERY DEVICES LIMITED Dispenser
D613848, Feb 16 2006 Glaxo Group Limited Inhalation device
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 12 2010WHITE, JOHN S 3M Innovative Properties CompanyASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0243410927 pdf
May 04 20103M Innovative Properties Company(assignment on the face of the patent)
Feb 25 20143M Innovative Properties CompanyAdamis Pharmaceuticals CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0326260357 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule